Characterizing safety, toxicity, and breast cancer risk reduction using a long-term fulvestrant eluting implant - PMC
pmc.ncbi.nlm.nih.gov · saved by 1 readers
For individuals at high risk of developing breast cancer, interventions to mitigate this risk include surgical removal of their breasts and ovaries or five years treatment with the anti-estrogen tamoxifen or aromatase inhibitors. We hypothesized ...